Related Experiment Video
Updated: Apr 3, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
1.0K
Breast Cancer Survival among African-Americans Living in the Midwest: Disparities and Recommendations to Decrease
Journal of National Black Nurses' Association : JNBNA
|September 16, 2015
Summary
African-American women in Nebraska have a significantly lower 5-year breast cancer survival rate (43%) compared to White women (75%). Factors like late-stage diagnosis and lower socioeconomic status contribute to this disparity.
Area of Science:
- Oncology
- Public Health
- Health Disparities
Background:
- Socioeconomic status significantly impacts breast cancer risk and outcomes.
- Omaha, Nebraska faces high African-American poverty rates and healthcare access challenges.
- Breast cancer survivorship disparities exist among African-American women in Nebraska.
Purpose of the Study:
- To establish a baseline for breast cancer survivorship among African-American women in Nebraska.
- To examine the 5-year survival difference between African-American and White women.
- To identify factors associated with poor breast cancer survival in this population.
Main Methods:
- Analysis of state cancer registry data.
- Comparison of 5-year breast cancer survivorship rates between African-American and White women.
- Multivariable analysis to identify independent factors associated with survival.
Main Results:
- The 5-year survival rate for African-American women was 43%, compared to 75% for White women.
- This survival disparity persisted even after accounting for cancer staging differences.
- Independent factors associated with reduced survival included being African-American, older age, late-stage diagnosis, and lower socioeconomic status.
Conclusions:
- Targeted health promotion and education programs for younger African-American women are recommended due to earlier diagnosis.
- The high proportion of late-stage diagnoses emphasizes the need for universal breast cancer education.
- Future research should investigate treatment quality, timing, and comorbidity issues affecting African-American women.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Comparing the Survival Analysis of Two or More Groups
711
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
711
Cancer-Critical Genes II: Tumor Suppressor Genes
10.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Kaplan-Meier Approach
741
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
741

